0 followers
G1 Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the discovery, development and delivery of next generation therapies that improve the lives of those affected by cancer, including the Company’s first commercial product, COSELA™ (Trilaciclib).
Kura Oncology
17 followers
SpringWorks Therapeutics
5 followers
Immunovant
5 followers
Prime Medicine
3 followers
Pivot Bio
2 followers
Garuda Therapeutics
4 followers
Relay Therapeutics
1 follower
Genesis Therapeutics
2 followers
CHDI Foundation
5 followers
Eikon Therapeutics
1 follower
Parse Biosciences
1 follower
Explore companies